2016 formulary exclusions in 9 key areas
CVS/Caremark and Express Scripts, the two biggest players in the pharmacy benefits management industry, have both added medications to their exclusion lists.
“Pharmacists are the drug experts. Call us first!”
Independent community pharmacists found plenty to think about at the recent McKesson ideaShare Conference in San Diego.
Natpara, a new treatment for hypoparathyroidism
Natpara is indicated only as adjunctive therapy to calcium and vitamin D supplementation and is available only through a restricted REMS program.
Nine tips on how to manage like a boss
Three community pharmacy professionals share their top tips on what makes pharmacists successful managers.
Biosimilars and interchangeability: Many questions, few answers
Interchangeability means different things to different stakeholders. Here are some things they will need to agree on.
What’s holding up biosimilar development?
Canada, the E.U., South Korea, Japan, India, and Australia - all have had clear regulatory pathways in place for years. The United States has been working on a biosimilars pathway for almost a decade. What's different?
The five forces that shape the biosimilar pipeline
The biosimilars pipeline is flush with new products, and it could be shortening. Here's why.
Drug shortages on the decline
The picture looks somewhat better than it did a year ago, but many challenges remain.
The pharmacist’s calling is to educate patients
Today’s pharmacist is much more than a healthcare professional who oversees the distribution of drugs. Pharmacists can be and often are the patient’s first-line healthcare educator and risk manager.
Denver area pharmacy draws penalty for HIPAA privacy violation
Note to pharmacies: Don't throw unshredded patient heath information into Dumpsters. Just don't.
Does folic acid reduce stroke risk?
New studies say yes.
Indie pharmacists find Rx for success at McKesson ideaShare
Three successful pharmacy owners tell us how it's done.
Safeguarding the U.S. drug supply
The product-tracing deadline has been extended to November 1. Other requirements are on schedule. Here's what you have to do, and when you have to do it.
Birth control and med adherence are connected how?
What does birth control have to do with medication adherence? David Stanley connects the dots.
Don’t like working for “The Man”? Do something about it!
Confronted by overwhelming workplace challenges, pharmacists sometimes forget they have options. It's time to step outside the limits of habitual thinking and take a look around.
Compounding after NECC: Higher standards, superior outcomes
Sterile compounders have voluntarily undertaken several upgrades to their processes and products. The results benefit patients, pharmacists, and the profession overall.
The market side of biosimilars
R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Marketing your pharmacy through social media
Some tips on making community connections
A host of new generics launch in 2015
A look at some of the year's launches from key manufacturers.
Jump start your immunization practice with “The Pink Book”
Start your immunization practice here.
Drug Topics Voices 08-10-2015
Letters, e-mails, posts, and comments from Drug Topics readers
Heading into mosquito territory? Here’s what you need
Some OTC products designed to keep those summer adventures fun
New Products for Pharmacists 08-10-2015
New Rx, generics, and OTC
McKesson conference explores the future of independent pharmacies
Community pharms discuss competitive options at McKesson's ideaShare.
CVS, hospitals undertake naloxone pharmacy study
Researchers plan to study the best way to deploy pharmacy-based naloxone rescue kits to help prevent opioid overdoses and deaths.
California pharmacist sentenced for Medicare fraud
The owner of a Los Angeles pharmacy was recently sentenced to 18 months in prison after pleading guilty to charges he participated in a fraud scheme involving the Medicare Part D prescription drug program.
CVS/Caremark dropping Viagra from its coverage list
Beginning next year, CVS/Caremark will no longer provide insurance coverage for the erectile dysfunction drug Viagra.
Pharmacy mistakes, Part 3: State BOPs and public safety
When people are injured by pharmacy mistakes, it is a public safety issue. Where are the state boards of pharmacy?
CVS reports strong second quarter with specialty pharmacy growth
CVS Health reported a strong second quarter in 2015 with overall net revenue up 7.4% to $37.2 million, compared to the same period last year.
CVS harnessing IBM’s Watson to improve patient care
CVS Health is partnering with IBM to document and analyze patient behaviors so that pharmacists and other healthcare professionals can better manage chronic illnesses.
